ALC Stock Rises Following the Merger Agreement With LENSAR

Alcon (ALC) and LENSAR, Inc. (LNSR) , a global medical technology company focused on advanced laser solutions for the treatment of cataracts, recently entered into a definitive merger agreement. Per the agreement, Alcon will acquire LENSAR’s ALLY Robotic Cataract Laser Treatment System, proprietary Streamline software technology and LENSAR legacy laser system. Alcon anticipates to close the transaction by mid-to-late 2025. The latest acquisition is expected to bolster its Surgical business.Alcon Stock’s Lik ...